.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Cerilliant
Boehringer Ingelheim
Daiichi Sankyo
Deloitte
Mallinckrodt
UBS
Colorcon
Johnson and Johnson
Novartis

Generated: July 25, 2017

DrugPatentWatch Database Preview

EPINASTINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Epinastine Hydrochloride, and what generic Epinastine Hydrochloride alternatives are available?

Epinastine Hydrochloride is a drug marketed by Apotex, Sun Pharm Inds, Somerset Theraps Llc, Akorn, Breckenridge Pharm, and Sandoz Inc. and is included in six NDAs.

The generic ingredient in EPINASTINE HYDROCHLORIDE is epinastine hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the epinastine hydrochloride profile page.

Summary for Tradename: EPINASTINE HYDROCHLORIDE

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list5
Bulk Api Vendors: see list41
Clinical Trials: see list2,258
Patent Applications: see list300
Drug Prices:see details
DailyMed Link:EPINASTINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: EPINASTINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC090919-001Oct 31, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC204055-001May 5, 2017ATRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC091626-001Oct 31, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Somerset Theraps Llc
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC090951-001Oct 31, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC203384-001Dec 7, 2016ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Dow
Cipla
UBS
AstraZeneca
Express Scripts
Cantor Fitzgerald
Colorcon
McKinsey
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot